Literature DB >> 32727223

The multi-functional eyes absent proteins.

Rashmi S Hegde1, Kaushik Roychoudhury1, Ram Naresh Pandey1.   

Abstract

The Eyes Absent (EYA) proteins are the only known instance of a single polypeptide housing the following three separable biochemical activities: tyrosine phosphatase, threonine phosphatase, and transactivation. This uniquely positions the EYAs to participate in both transcriptional regulation and signal transduction pathways. But it also complicates the assignment of biological roles to individual biochemical activities through standard loss-of-function experiments. Nevertheless, there is an emerging literature linking developmental and pathological functions with the various EYA activities, and a growing list of disease states that might benefit from EYA-targeted therapeutics. There also remain multiple unresolved issues with significant implications for our understanding of how the EYAs might impact such ubiquitous signaling cascades as the MYC and Notch pathways. This review will describe the unique juxtaposition of biochemical activities in the EYAs, their interaction with signaling pathways and cellular processes, emerging evidence of roles in disease states, and the feasibility of therapeutic targeting of individual EYA activities. We will focus on the phosphatase activities of the vertebrate EYA proteins and will examine the current state of knowledge regarding: • substrates and signaling pathways affected by the EYA tyrosine phosphatase activity; • modes of regulation of the EYA tyrosine phosphatase activity; • signaling pathways that implicate the threonine phosphatase activity of the EYAs including a potential interaction with PP2A-B55α; • the interplay between the two phosphatase activities and the transactivation function of the EYAs; • disease states associated with the EYAs and the current state of development of EYA-targeted therapeutics.

Entities:  

Keywords:  DNA damage repair; EYA; Eyes Absent; H2AX; MYC; Notch; PTP; threonine phosphatase

Mesh:

Substances:

Year:  2020        PMID: 32727223      PMCID: PMC7727457          DOI: 10.1080/10409238.2020.1796922

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  73 in total

1.  Eyes absent represents a class of protein tyrosine phosphatases.

Authors:  Jayanagendra P Rayapureddi; Chandramohan Kattamuri; Brian D Steinmetz; Benjamin J Frankfort; Edwin J Ostrin; Graeme Mardon; Rashmi S Hegde
Journal:  Nature       Date:  2003-11-20       Impact factor: 49.962

2.  The phosphatase-transcription activator EYA1 is targeted by anaphase-promoting complex/Cdh1 for degradation at M-to-G1 transition.

Authors:  Jianbo Sun; Zoi Karoulia; Elaine Y M Wong; Mohi Ahmed; Keiji Itoh; Pin-Xian Xu
Journal:  Mol Cell Biol       Date:  2012-12-21       Impact factor: 4.272

Review 3.  Regulation of protein tyrosine phosphatases by reversible oxidation.

Authors:  Arne Ostman; Jeroen Frijhoff; Asa Sandin; Frank-D Böhmer
Journal:  J Biochem       Date:  2011-08-19       Impact factor: 3.387

4.  A comparative study of Eya1 and Eya4 protein function and its implication in branchio-oto-renal syndrome and DFNA10.

Authors:  Yuzhou Zhang; Boyd M Knosp; Mark Maconochie; Rick A Friedman; Richard J H Smith
Journal:  J Assoc Res Otolaryngol       Date:  2004-06-24

Review 5.  Protein tyrosine phosphatase function: the substrate perspective.

Authors:  Tony Tiganis; Anton M Bennett
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

6.  The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells.

Authors:  R N Pandey; R Rani; E-J Yeo; M Spencer; S Hu; R A Lang; R S Hegde
Journal:  Oncogene       Date:  2010-04-26       Impact factor: 9.867

7.  Interactions with the Abelson tyrosine kinase reveal compartmentalization of eyes absent function between nucleus and cytoplasm.

Authors:  Wenjun Xiong; Noura M Dabbouseh; Ilaria Rebay
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

8.  A phosphotyrosine switch determines the antitumor activity of ERβ.

Authors:  Bin Yuan; Long Cheng; Huai-Chin Chiang; Xiaojie Xu; Yongjian Han; Hang Su; Lingxue Wang; Bo Zhang; Jing Lin; Xiaobing Li; Xiangyang Xie; Tao Wang; Rajeshwar R Tekmal; Tyler J Curiel; Zhi-Min Yuan; Richard Elledge; Yanfen Hu; Qinong Ye; Rong Li
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

9.  EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival.

Authors:  Hanxiao Xu; Ying Jiao; Ming Yi; Weiheng Zhao; Kongming Wu
Journal:  Front Oncol       Date:  2019-01-29       Impact factor: 6.244

10.  CDK6 binds and promotes the degradation of the EYA2 protein.

Authors:  Dawn Kohrt; Jennifer Crary; Marc Zimmer; Aaron N Patrick; Heide L Ford; Philip W Hinds; Martha J Grossel
Journal:  Cell Cycle       Date:  2013-10-12       Impact factor: 4.534

View more
  5 in total

Review 1.  Friend or foe? Unraveling the complex roles of protein tyrosine phosphatases in cardiac disease and development.

Authors:  Maike Krenz
Journal:  Cell Signal       Date:  2022-03-05       Impact factor: 4.850

2.  Targeting EYA3 in Ewing Sarcoma Retards Tumor Growth and Angiogenesis.

Authors:  Yuhua Wang; Ram Naresh Pandey; Kaushik Roychoudhury; David Milewski; Tanya V Kalin; Sara Szabo; Joseph G Pressey; Rashmi S Hegde
Journal:  Mol Cancer Ther       Date:  2021-03-01       Impact factor: 6.009

Review 3.  The Eyes Absent Proteins: Unusual HAD Family Tyrosine Phosphatases.

Authors:  Kaushik Roychoudhury; Rashmi S Hegde
Journal:  Int J Mol Sci       Date:  2021-04-10       Impact factor: 5.923

4.  The transcriptional coactivator Eya1 exerts transcriptional repressive activity by interacting with REST corepressors and REST-binding sequences to maintain nephron progenitor identity.

Authors:  Jun Li; Chunming Cheng; Jinshu Xu; Ting Zhang; Bengu Tokat; Georgia Dolios; Aarthi Ramakrishnan; Li Shen; Rong Wang; Pin-Xian Xu
Journal:  Nucleic Acids Res       Date:  2022-10-14       Impact factor: 19.160

Review 5.  The Eyes Absent proteins in development and in developmental disorders.

Authors:  Upendra Kumar Soni; Kaushik Roychoudhury; Rashmi S Hegde
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.